Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-23 Sale |
2024-01-25 4:32 pm |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Dissanayake Shehan Bharatha Fuglesang Christopher Braslyn Ltd. Lockend Five LLC See remarks |
6,859,544 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:38 pm |
Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director |
16,222 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:38 pm |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
11,252 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:38 pm |
Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director |
54,325 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
17,273 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
17,273 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
24,752 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Ondrey Aaron Chief Financial Officer |
39,461 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Moriarty John B Chief Legal Officer |
72,335 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
117,028 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
17,273 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
79,865 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
154,996 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M Founder, President, and CEO |
237,871 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Gallagher Carol Giltner Director |
14,363 | $0 | $0 | 0 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:45 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
1,597 | $59.02 | $94,255 | 117,028 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:38 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
1,597 | $59.02 | $94,255 | 155,927 (Direct) |
View |
| 2024-01-08 Sale |
2024-01-09 5:54 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
2,090 | $58.92 | $123,143 | 118,625 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 5:34 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
1,531 | $58.81 | $90,038 | 157,135 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-19 4:59 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
2,387 | $57.5 | $137,253 | 141,645 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-14 5:05 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
2,220 | $56.67 | $125,807 | 103,694 (Direct) |
View |
| 2023-09-08 Sale |
2023-09-12 5:41 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
2,388 | $35.63 | $85,084 | 144,032 (Direct) |
View |
| 2023-08-11 Purchase |
2023-08-15 9:39 pm |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Dissanayake Shehan Bharatha Fuglesang Christopher See remarks |
1,258,973 | $27.8 | $34,999,449 | 6,672,789 (Indirect Direct) |
View |
| 2023-08-11 Purchase |
2023-08-15 9:38 pm |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Dissanayake Shehan Bharatha Fuglesang Christopher See remarks |
1,258,973 | $27.8 | $34,999,449 | 6,672,789 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-29 Option Award |
2024-01-03 8:50 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director |
6,808 | $58.75 | 54,325 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:37 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
6,808 | $58.75 | 17,273 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:32 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
6,808 | $58.75 | 17,273 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:27 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Gallagher Carol Giltner Director |
6,808 | $58.75 | 14,363 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:24 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director |
6,808 | $58.75 | 16,222 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:22 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
6,808 | $58.75 | 11,252 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:18 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
9,702 | $58.75 | 24,752 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:16 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
6,808 | $58.75 | 17,273 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:13 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
17,021 | $58.75 | 120,715 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:05 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
17,021 | $58.75 | 158,666 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:01 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
17,021 | $58.75 | 79,318 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:55 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Ondrey Aaron CFO |
17,021 | $58.75 | 39,461 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:52 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M Interim CEO |
20,425 | $58.75 | 247,700 (Direct) |
View |
Ownership |
2023-12-27 4:04 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | EcoR1 Capital LLC 10% Owner |
0 | $0 | 7,396,979 (Indirect) |
View |
| 2023-09-08 Option Award |
2023-09-12 5:30 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Ondrey Aaron Interim CFO |
8,412 | $35.66 | 22,440 (Direct) |
View |
Ownership |
2023-09-12 5:27 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Ondrey Aaron Interim CFO |
0 | $0 | 37,805 (Direct) |
View |